GlassScriptPhysician profile
Akinrinola Fatoki
NPI 1346354693
$932.14
in general payments reported to CMS, 2019-2025
19 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $178 · 2021: $64.65 · 2022: $118 · 2023: $132 · 2024: $53.10 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $185.22 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $124.54 | 2021-2025 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $113.49 | 2019-2025 | Airsupra |
| Novartis Pharmaceuticals Corporation | $91.41 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $64.84 | 2022-2023 | Xarelto |
| Aimmune Therapeutics, INC. | $43.62 | 2025 | Zenpep |
| Pfizer INC. | $36.97 | 2023-2024 | |
| Glaxosmithkline, LLC. | $34.26 | 2020-2023 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $33.28 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.77 | 2022 | |
| Astellas Pharma US INC | $22.86 | 2019 | |
| Exact Sciences Corporation | $22.08 | 2025 | Cologuard Collection Kit |
| Vbi Vaccine (Delaware) INC. | $21.22 | 2022 | |
| Amgen INC. | $20.85 | 2024 | Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $18.74 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $18.33 | 2020 | |
| Xeris Pharmaceuticals, INC. | $16.53 | 2025 | Keveyis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.22 | 2019 | |
| Neurelis, INC. | $15.91 | 2024 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akinrinola Fatoki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.